Erasmus Medical Center, Rotterdam
Melanoma survival in the Netherlands unaffected by non-compliance to re-excision guidelines
Published in Biotech Law Weekly, May 5th, 2006
According to a recently published report, investigators in the Netherlands conducted a study "to evaluate causes and consequences of not adhering to the clinical practice guideline for cutaneous malignant melanoma. We conducted a retrospective cohort study of the clinical records of 454 subjects whose pathological reports were obtained from a population-based cancer registry to assess determinants and effects of non-compliance of physicians with the excision policy and the related clinical practice guideline for patients with primary localized cutaneous malignant melanoma...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-05-05)
More Articles from Biotech Law Weekly
- Bioniche Life Sciences, Inc.
Bioniche receives U.S. FDA approval to proceed with phase III bladder cancer trials - Cobalis Corp.
Cobalis settles outstanding litigation with Gryphon Master Fund, L.P. - Hospice
VITAS hospice secures state license, Medicare certification for north Virginia opening - Market Analysis
Report suggests only 20% of seniors expect to enroll in a prescription drug plan - Medicare
AHIP member plans work with AMA, beneficiary groups to simplify Medicare Part D administration - Medicare
Progress report shows many seniors are choosing alternatives to the standard Medicare drug plan - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
